Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Unicycive Therapeutics Inc increased its cash reserves by 2,032.09%, or 9.25m. Cash Flow from Financing totalled 27.54m or 4,080.15% of revenues. In addition the company used 18.28m for operations while cash used for investing totalled 12.00k.
Cash flow per share | -0.491 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.7193 |
---|---|
Tangible book value per share | 0.7193 |
More ▼
Balance sheet in USDView more
Current ratio | 3.37 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼